{"id":"https://openalex.org/W2329335673","doi":"https://doi.org/10.1158/1538-7445.am2012-1385","title":"Abstract 1385: Molecular changes in breast tumors following bevacizumab-based treatment: Final analysis of a randomized neoadjuvant study of bevacizumab or placebo, followed by chemotherapy with or without bevacizumab, in patients with stage II or III breast cancer","display_name":"Abstract 1385: Molecular changes in breast tumors following bevacizumab-based treatment: Final analysis of a randomized neoadjuvant study of bevacizumab or placebo, followed by chemotherapy with or without bevacizumab, in patients with stage II or III breast cancer","publication_year":2012,"publication_date":"2012-04-01","ids":{"openalex":"https://openalex.org/W2329335673","doi":"https://doi.org/10.1158/1538-7445.am2012-1385","mag":"2329335673"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2012-1385","doi":"https://doi.org/10.1158/1538-7445.am2012-1385","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1385","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068059897","display_name":"Sara Alsterlind Hurvitz","orcid":"https://orcid.org/0000-0001-7808-7191","observed_orcids":["https://orcid.org/0000-0001-7808-7191"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara A. Hurvitz","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110860414","display_name":"Priti S. Hegde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priti Hegde","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089040548","display_name":"Linda D. Bosserman","orcid":"https://orcid.org/0000-0003-3897-4276","observed_orcids":["https://orcid.org/0000-0003-3897-4276"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Bosserman","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111720856","display_name":"Mary Ann Allison","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Ann Allison","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030138461","display_name":"Michael P. Thirlwell","orcid":"https://orcid.org/0000-0002-7412-4642","observed_orcids":["https://orcid.org/0000-0002-7412-4642"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Thirlwell","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062873463","display_name":"Ru\u2010Fang Yeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ru-Fang Yeh","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100726024","display_name":"Ling Lin Fu","orcid":"https://orcid.org/0000-0002-5918-3978","observed_orcids":["https://orcid.org/0000-0002-5918-3978"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ling Fu","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014772212","display_name":"Maike Schmidt","orcid":"https://orcid.org/0000-0002-3024-882X","observed_orcids":["https://orcid.org/0000-0002-3024-882X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maike Schmidt","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068271757","display_name":"Brian R Leyland-Jones","orcid":"https://orcid.org/0000-0003-2434-0774","observed_orcids":["https://orcid.org/0000-0003-2434-0774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian Leyland-Jones","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eleonor Quan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eleonor Quan","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090998420","display_name":"David C. Molthrop","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Molthrop","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023485078","display_name":"John L. Barstis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Barstis","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"David Park","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Park","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109189763","display_name":"Maccon Keane","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maccon Keane","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085310064","display_name":"Gargi H. Upadhyaya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gargi Upadhyaya","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079711525","display_name":"Giribala Patel","orcid":"https://orcid.org/0000-0002-3321-1010","observed_orcids":["https://orcid.org/0000-0002-3321-1010"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giribala Patel","raw_affiliation_strings":["3Translational Oncology Research International, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Translational Oncology Research International, Los Angeles, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058746565","display_name":"Steven Applebaum","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Applebaum","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066999153","display_name":"Judy Dering","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judy Dering","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073689791","display_name":"Charles Ginther","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Ginther","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109218027","display_name":"Brad Adams","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad Adams","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038215538","display_name":"Daniel S. Chen","orcid":"https://orcid.org/0000-0001-5085-3579","observed_orcids":["https://orcid.org/0000-0001-5085-3579"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel S. Chen","raw_affiliation_strings":["2Genentech, South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015491002","display_name":"Dennis J. Slamon","orcid":"https://orcid.org/0000-0002-6330-498X","observed_orcids":["https://orcid.org/0000-0002-6330-498X"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis J. Slamon","raw_affiliation_strings":["1UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"72","issue":"8_Supplement","first_page":"1385","last_page":"1385"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.6122999787330627,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.37790000438690186,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.8569999933242798},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8980000019073486},{"id":"https://openalex.org/keywords/tac-regimen","display_name":"TAC regimen","score":0.7020000219345093},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-gene-expression","display_name":"cancer gene expression","score":0.5619999766349792},{"id":"https://openalex.org/keywords/tumor-vasculature","display_name":"tumor vasculature","score":0.6259999871253967},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.7760000228881836},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.8309999704360962},{"id":"https://openalex.org/keywords/locally-advanced-breast-cancer","display_name":"locally advanced breast cancer","score":0.6880000233650208},{"id":"https://openalex.org/keywords/wound-complications","display_name":"wound complications","score":0.7160000205039978},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8979277610778809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8722403049468994},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6838256120681763},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6032806038856506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.539016842842102},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.519376814365387},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5176551938056946},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.48339787125587463},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.46914806962013245},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.43431979417800903},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.42846691608428955},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.40015655755996704},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36440110206604004},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.33553367853164673},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.23473095893859863},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2012-1385","doi":"https://doi.org/10.1158/1538-7445.am2012-1385","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2012-1385","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2227963973","https://openalex.org/W4250614202","https://openalex.org/W1921704765","https://openalex.org/W2944740122","https://openalex.org/W4256311684","https://openalex.org/W2624490253","https://openalex.org/W2030722611","https://openalex.org/W2332558266","https://openalex.org/W2122574381","https://openalex.org/W327317652"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Bevacizumab":[2],"(bev)":[3],"has":[4,18],"been":[5],"widely":[6],"studied":[7],"in":[8,16,20,173,205,219,267,273,280,290,304,310,341,355,358,407,422,436,480],"breast":[9,174,449],"cancer":[10,450],"(BC),":[11],"yet":[12],"no":[13,153],"randomized":[14,55],"trial":[15,33,441],"BC":[17],"reported":[19],"vivo":[21],"molecular":[22,40,446],"effects":[23,41,181],"of":[24,42,59,108,117,182,210,288,360,373,415,429,448,504,509],"bev":[25,46,80,97,109,131,145,337,430,457,489],"on":[26,186,198,431],"human":[27],"tumor":[28,187,451,494],"tissue.":[29],"We":[30],"conducted":[31],"a":[32,216,356],"to":[34,57,146,207,214,227,231,236,345,473],"evaluate":[35,208],"the":[36,180,192,201,342,374,396,413,427,437,443,481,485,505,510],"safety,":[37],"clinical":[38,444],"&":[39,175],"neoadjuvant":[43],"chemotherapy":[44],"plus":[45,119],"for":[47,262,478,513],"locally":[48],"advanced":[49],"BC.":[50,164],"Methods:":[51],"90":[52],"pts":[53,224,240,265,271,278,289],"were":[54,134,158,225,339,350,390,399],"(2:1:2:1)":[56],"1":[58],"4":[60,299],"arms:":[61],"Arm":[62,83,91,100,228,232,248,274,281,291,318,322],"A:":[63,70],"TAC":[64,85,93,102,118],"(docetaxel,":[65],"T:":[66],"75":[67],"mg/m2,":[68,72],"doxorubicin,":[69],"50":[71],"cyclophosphamide,":[73],"C:":[74,92],"500":[75],"mg/m2)":[76],"+":[77,86,94,103],"low":[78,87],"dose":[79,88,96],"(7.5":[81],"mg/kg);":[82,99],"B:":[84],"placebo":[89],"(P);":[90],"standard":[95],"(15":[98],"D:":[101],"Std-P.":[104],"A":[105,275],"run-in":[106],"cycle":[107],"or":[110,121,132,297,388],"P":[111,120,133],"was":[112,196,313,381,458],"followed":[113],"by":[114],"6":[115,324,347],"cycles":[116],"bev.":[122],"Tumor":[123,475],"biopsies":[124],"pre-":[125,202],"and":[126,168,203,234,252,259,276,334,368,402,445,454,464,468],"7-10":[127],"days":[128],"post-run-in":[129],"with":[130,160,460],"taken.":[135],"Unblinding":[136],"occurred":[137],"post":[138],"surgery":[139,245],"(Sx):":[140],"Arms":[141,150,237,250,268,305,326,332],"A/C":[142],"received":[143,152,254],"maintenance":[144],"complete":[147,170],"52":[148],"wks,":[149],"B/D":[151,333],"further":[154],"P.":[155,474],"Eligible":[156],"patients":[157,312],"females":[159],">3":[161],"cm,":[162],"HER2(-)":[163],"Endpoints":[165],"included":[166,340],"safety":[167],"pathologic":[169],"response":[171],"(pCR)":[172],"lymph":[176],"nodes.":[177],"To":[178],"assess":[179],"VEGF":[183,220],"pathway":[184,483],"inhibition":[185],"vasculature,":[188],"PCR":[189],"analysis":[190,344,477],"using":[191],"fluidigm":[193],"array":[194],"platform":[195],"performed":[197],"RNA":[199],"from":[200,331,336],"post-run":[204],"samples":[206,329],"expression":[209,359,476],"67":[211],"genes":[212,348,384,397,405,424,479],"known":[213],"play":[215],"defined":[217],"role":[218],"signaling.":[221],"Results:":[222],"28":[223],"assigned":[226],"A,":[229,319],"30":[230],"C,":[233,323],"32":[235],"B/D.":[238,327],"12":[239],"came":[241],"off":[242],"Tx":[243],"before":[244],"(Arm":[246],"A:2,":[247],"C:6,":[249],"B/D:4)":[251],"78":[253],"all":[255],"Tx,":[256],"underwent":[257],"Sx":[258],"are":[260],"evaluable":[261,311],"pCR.":[263],"Two":[264],"(6%)":[266],"B/D,":[269],"5":[270,316],"(18%)":[272],"10":[277],"(33%)":[279],"C":[282,292],"had":[283,293],"wound":[284,462],"healing":[285,463],"complications.":[286],"17%":[287],"Gr":[294,298],"3":[295,320],"(N=4)":[296],"(N=1)":[300],"heart":[301,465],"failure,":[302],"none":[303],"A/B/D.":[306],"The":[307,420],"pCR":[308,470],"rate":[309],"18%":[314],"(14/78):":[315],"(19%)":[317],"(13%)":[321],"(21%)":[325],"45":[328],"(20":[330],"25":[335],"arms)":[338],"pair-wise":[343],"identify":[346],"that":[349,398,488],"differentially":[351,393],"expressed.":[352,394],"Bev":[353],"resulted":[354],"decrease":[357,421],"Dll4,":[361],"Cox2,":[362],"Fibronectin":[363],"(FN_EIIIB),":[364],"angiopoietin":[365],"2":[366],"(Angpt2)":[367],"ESM1.":[369],"In":[370],"addition,":[371],"upregulation":[372],"cytokine,":[375],"stromal":[376],"derived":[377],"growth":[378],"factor":[379],"(SDF1)":[380],"observed.":[382],"Notably,":[383],"such":[385],"as":[386],"CD31":[387],"VE-cadherin":[389],"not":[391],"appreciably":[392],"Of":[395],"downregulated,":[400],"Dll4":[401],"Angpt2":[403],"represent":[404],"enriched":[406],"endothelial":[408],"tip":[409],"cells,":[410],"which":[411],"guide":[412],"migration":[414],"newly":[416],"formed":[417],"blood":[418],"vessels.":[419],"these":[423],"likely":[425],"represents":[426],"effect":[428],"reducing":[432],"immature,":[433],"growing":[434],"vasculature":[435],"tumor.":[438],"Conclusions:":[439],"This":[440],"enabled":[442],"evaluation":[447],"tissue":[452],"pre":[453],"post-bev.":[455],"Clinically,":[456],"associated":[459],"more":[461],"failure":[466],"events":[467],"similar":[469],"rates":[471],"compared":[472],"angiogenesis":[482],"supports":[484],"preclinical":[486],"hypothesis":[487],"may":[490],"primarily":[491],"target":[492],"immature":[493],"vasculature.":[495],"Citation":[496],"Format:":[497],"{Authors}.":[498],"{Abstract":[499],"title}":[500],"[abstract].":[501],"In:":[502],"Proceedings":[503],"103rd":[506],"Annual":[507],"Meeting":[508],"American":[511],"Association":[512],"Cancer":[514,525],"Research;":[515],"2012":[516],"Mar":[517],"31-Apr":[518],"4;":[519],"Chicago,":[520],"IL.":[521],"Philadelphia":[522],"(PA):":[523],"AACR;":[524],"Res":[526],"2012;72(8":[527],"Suppl):Abstract":[528],"nr":[529],"1385.":[530],"doi:1538-7445.AM2012-1385":[531]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}